Id |
Subject |
Object |
Predicate |
Lexical cue |
T263 |
0-29 |
Sentence |
denotes |
Advance/intervention Measures |
T264 |
30-118 |
Sentence |
denotes |
Non-pharmaceutical interventions Announcing the potential of human-to-human transmission |
T265 |
119-180 |
Sentence |
denotes |
Lockdown of Wuhan and other adjacent cities in Hubei province |
T266 |
181-227 |
Sentence |
denotes |
Imposing restrictions on all social activities |
T267 |
228-284 |
Sentence |
denotes |
Enforcing national and international travel restrictions |
T268 |
285-287 |
Sentence |
denotes |
|
T269 |
288-399 |
Sentence |
denotes |
Clinical characterization and epidemiologic advances Comprehensive characterization of the viral ultrastructure |
T270 |
400-479 |
Sentence |
denotes |
Revealing the route for SARS-CoV-2 transmission (including fomite transmission) |
T271 |
480-549 |
Sentence |
denotes |
Defining the clinical and epidemiological characteristics of COVID-19 |
T272 |
550-608 |
Sentence |
denotes |
Demonstration of the immune regulation network of COVID-19 |
T273 |
609-691 |
Sentence |
denotes |
AI prediction of the epidemics trend of COVID-19 under public health interventions |
T274 |
692-694 |
Sentence |
denotes |
|
T275 |
695-923 |
Sentence |
denotes |
Therapeutic interventions Validation of the efficacy and safety of repurposed drugs, especially traditional Chinese medicines (Lianhuaqingwen capsule, Xuebijing injection, and Liu Shen capsule), for accelerating symptom recovery |
T276 |
924-1158 |
Sentence |
denotes |
Validation of the efficacy and safety of H2–O2 inhalation and endorsement by the National Health Commission of the People’s Republic of China for COVID-19 patients with dyspnea or those in facilities without sufficient oxygen supplies |
T277 |
1159-1274 |
Sentence |
denotes |
Validation of the efficacy and safety of granulocyte colony stimulating factor for patients with marked lymphopenia |
T278 |
1275-1277 |
Sentence |
denotes |
|
T279 |
1278-1349 |
Sentence |
denotes |
Diagnosis Development of PCR- and serology-based rapid detection method |
T280 |
1350-1444 |
Sentence |
denotes |
Development of the portable, laboratory-instrument-independent CRISPR/Cas method for detection |
T281 |
1445-1447 |
Sentence |
denotes |
|
T282 |
1448-1567 |
Sentence |
denotes |
Prognostic prediction Identification of hematologic and immunologic biomarkers that correlate with the disease severity |
T283 |
1568-1655 |
Sentence |
denotes |
Establishment of AI model to predict the likelihood of developing into critical illness |